Nursing practice questions with comprehensive rationales
NurseDive Free Nursing Practice Question
A nurse is teaching a client who is newly diagnosed with Alzheimer's disease and their family about newly prescribed medications for Alzheimer's disease. Which statement by the client indicates the teaching was effective?
A. "Medications for Alzheimer's disease will help to increase my energy levels."
"Medications for Alzheimer's disease will help to increase my energy levels": This statement is not accurate. Medications for Alzheimer's disease, such as cholinesterase inhibitors (e.g., donepezil, rivastigmine) and memantine, are not intended to increase energy levels. Their primary goal is to improve cognitive function and help manage symptoms associated with Alzheimer's disease, but they do not directly affect energy levels.
B. "Medications for Alzheimer's disease will help slow the progression of my disease."
"Medications for Alzheimer's disease will help slow the progression of my disease": This statement is correct. Medications used to treat Alzheimer's disease, such as cholinesterase inhibitors and memantine, are aimed at slowing the progression of cognitive decline and managing symptoms associated with the disease. While these medications cannot cure Alzheimer's disease, they can help improve cognitive function and quality of life for some individuals.
C. "Medications for Alzheimer's disease will help me remember what I forgot."
"Medications for Alzheimer's disease will help me remember what I forgot": This statement oversimplifies the effects of Alzheimer's medications. While these medications may help improve memory and cognition to some extent, they are not capable of restoring lost memories or reversing the effects of significant memory impairment caused by Alzheimer's disease.
D. "Medications for Alzheimer's disease will cure the disease."
"Medications for Alzheimer's disease will cure the disease": This statement is incorrect. Currently, there is no cure for Alzheimer's disease. Medications used to treat Alzheimer's, such as cholinesterase inhibitors and memantine, can help manage symptoms and slow disease progression, but they do not cure the underlying condition.
This question is an excerpt from Nurse Dive's nursing test bank - Ati Med Surg Proctored Exam 1 2024. Take the full exam now
Full Explanation
A. "Medications for Alzheimer's disease will help to increase my energy levels": This statement is not accurate. Medications for Alzheimer's disease, such as cholinesterase inhibitors (e.g., donepezil, rivastigmine) and memantine, are not intended to increase energy levels. Their primary goal is to improve cognitive function and help manage symptoms associated with Alzheimer's disease, but they do not directly affect energy levels.
B. "Medications for Alzheimer's disease will help slow the progression of my disease": This statement is correct. Medications used to treat Alzheimer's disease, such as cholinesterase inhibitors and memantine, are aimed at slowing the progression of cognitive decline and managing symptoms associated with the disease. While these medications cannot cure Alzheimer's disease, they can help improve cognitive function and quality of life for some individuals.
C. "Medications for Alzheimer's disease will help me remember what I forgot": This statement oversimplifies the effects of Alzheimer's medications. While these medications may help improve memory and cognition to some extent, they are not capable of restoring lost memories or reversing the effects of significant memory impairment caused by Alzheimer's disease.
D. "Medications for Alzheimer's disease will cure the disease": This statement is incorrect. Currently, there is no cure for Alzheimer's disease. Medications used to treat Alzheimer's, such as cholinesterase inhibitors and memantine, can help manage symptoms and slow disease progression, but they do not cure the underlying condition.
Similar Questions
A nurse is caring for a client who has a subarachnoid hemorrhage and asks why they are having a CT angiography. Which of the following should the nurse understand about CT angiography?
A. A CT angiogram will reveal any edema within the brain tissue.
A CT angiogram will reveal any edema within the brain tissue: CT angiography primarily focuses on visualizing blood vessels and blood flow within the brain. While it may incidentally detect areas of edema, its primary purpose is to assess vascular structures rather than brain tissue changes such as edema.
B. A CT angiogram will reveal any overproduction of cerebrospinal fluid (CSF).
A CT angiogram will reveal any overproduction of cerebrospinal fluid (CSF): CT angiography does not assess cerebrospinal fluid (CSF) production. Its main function is to visualize blood vessels and blood flow within the brain, particularly to detect abnormalities such as aneurysms, arteriovenous malformations, or vasospasm.
C. A CT angiogram will reveal any fractures within the skull or spine.
A CT angiogram will reveal any fractures within the skull or spine: CT angiography primarily focuses on imaging blood vessels and is not the preferred modality for detecting fractures within the skull or spine. CT scans or plain radiography are typically used to assess bony structures for fractures.
D. A CT angiogram will reveal any decreased blood flow related to vasospasm.
A CT angiogram will reveal any decreased blood flow related to vasospasm: This statement is correct. CT angiography is a specialized imaging technique that combines computed tomography (CT) scanning with contrast dye to visualize blood vessels and blood flow within the brain. It is commonly used to detect and monitor vasospasm, a potentially serious complication of subarachnoid hemorrhage, where blood vessels in the brain constrict, leading to decreased blood flow. CT angiography allows for the visualization of these changes in blood vessel diameter and blood flow dynamics.
Full Explanation
A. A CT angiogram will reveal any edema within the brain tissue: CT angiography primarily focuses on visualizing blood vessels and blood flow within the brain. While it may incidentally detect areas of edema, its primary purpose is to assess vascular structures rather than brain tissue changes such as edema.
B. A CT angiogram will reveal any overproduction of cerebrospinal fluid (CSF): CT angiography does not assess cerebrospinal fluid (CSF) production. Its main function is to visualize blood vessels and blood flow within the brain, particularly to detect abnormalities such as aneurysms, arteriovenous malformations, or vasospasm.
C. A CT angiogram will reveal any fractures within the skull or spine: CT angiography primarily focuses on imaging blood vessels and is not the preferred modality for detecting fractures within the skull or spine. CT scans or plain radiography are typically used to assess bony structures for fractures.
D. A CT angiogram will reveal any decreased blood flow related to vasospasm: This statement is correct. CT angiography is a specialized imaging technique that combines computed tomography (CT) scanning with contrast dye to visualize blood vessels and blood flow within the brain. It is commonly used to detect and monitor vasospasm, a potentially serious complication of subarachnoid hemorrhage, where blood vessels in the brain constrict, leading to decreased blood flow. CT angiography allows for the visualization of these changes in blood vessel diameter and blood flow dynamics.
A nurse is caring for a client who has a traumatic brain injury (TBI). Which of the following should the nurse understand is a risk factor for TBI?
A. Marfan's syndrome
Marfan's syndrome: Marfan's syndrome is a genetic disorder that affects the connective tissue in the body, predisposing individuals to various cardiovascular, skeletal, and ocular abnormalities. While Marfan's syndrome can present with certain cranial and intracranial manifestations, such as dural ectasia and intracranial aneurysms, it is not typically considered a direct risk factor for traumatic brain injury (TBI).
B. Hypercarbia
Hypercarbia: Hypercarbia refers to elevated levels of carbon dioxide (CO2) in the blood. While severe hypercarbia can lead to cerebral vasodilation and potentially exacerbate intracranial pressure in individuals with traumatic brain injury, it is not considered a direct risk factor for TBI itself.
C. Falls
Falls: Falls are a significant risk factor for traumatic brain injury (TBI), particularly in older adults and young children. Falls can occur due to various factors such as environmental hazards, impaired mobility, balance issues, or neurological conditions. Falls are a leading cause of TBI-related emergency department visits, hospitalizations, and fatalities.
D. Ventriculostomy
Ventriculostomy: Ventriculostomy involves the placement of a catheter into the ventricular system of the brain to monitor intracranial pressure (ICP) or drain cerebrospinal fluid (CSF). While ventriculostomy is a procedure commonly performed in the management of severe traumatic brain injury to monitor and manage intracranial pressure, it is not a risk factor for TBI itself.
Full Explanation
A. Marfan's syndrome: Marfan's syndrome is a genetic disorder that affects the connective tissue in the body, predisposing individuals to various cardiovascular, skeletal, and ocular abnormalities. While Marfan's syndrome can present with certain cranial and intracranial manifestations, such as dural ectasia and intracranial aneurysms, it is not typically considered a direct risk factor for traumatic brain injury (TBI).
B. Hypercarbia: Hypercarbia refers to elevated levels of carbon dioxide (CO2) in the blood. While severe hypercarbia can lead to cerebral vasodilation and potentially exacerbate intracranial pressure in individuals with traumatic brain injury, it is not considered a direct risk factor for TBI itself.
C. Falls: Falls are a significant risk factor for traumatic brain injury (TBI), particularly in older adults and young children. Falls can occur due to various factors such as environmental hazards, impaired mobility, balance issues, or neurological conditions. Falls are a leading cause of TBI-related emergency department visits, hospitalizations, and fatalities.
D. Ventriculostomy: Ventriculostomy involves the placement of a catheter into the ventricular system of the brain to monitor intracranial pressure (ICP) or drain cerebrospinal fluid (CSF). While ventriculostomy is a procedure commonly performed in the management of severe traumatic brain injury to monitor and manage intracranial pressure, it is not a risk factor for TBI itself.
A nurse is planning care for a client who has hypertrophic cardiomyopathy that has not improved after pharmacologic treatment. Which of the following procedures should the nurse anticipate the health care provider ordering?
A. Pericardiocentesis
Pericardiocentesis: Pericardiocentesis is a procedure used to drain fluid from the pericardial sac, typically performed in cases of pericardial effusion or cardiac tamponade. It is not indicated for the treatment of hypertrophic cardiomyopathy (HCM), which involves structural abnormalities of the heart muscle rather than pericardial fluid accumulation.
B. Septal myectomy
Septal myectomy: Septal myectomy is a surgical procedure performed to treat hypertrophic obstructive cardiomyopathy (HOCM), a subtype of hypertrophic cardiomyopathy characterized by thickening of the interventricular septum and dynamic left ventricular outflow tract obstruction. Septal myectomy involves the surgical removal of a portion of the hypertrophied septum to relieve left ventricular outflow tract obstruction and improve symptoms.
C. Pericardial window
Pericardial window: A pericardial window is a surgical procedure used to create a communication between the pericardial sac and the pleural space, typically performed in cases of recurrent pericardial effusion or tamponade to prevent fluid re-accumulation. It is not indicated for the treatment of hypertrophic cardiomyopathy.
D. Synchronized electrical cardioversion
Synchronized electrical cardioversion: Synchronized electrical cardioversion is a procedure used to restore normal sinus rhythm in patients with certain types of cardiac arrhythmias, such as atrial fibrillation or atrial flutter. It is not typically indicated for the treatment of hypertrophic cardiomyopathy, although patients with HCM may develop arrhythmias as a complication.
Full Explanation
A. Pericardiocentesis: Pericardiocentesis is a procedure used to drain fluid from the pericardial sac, typically performed in cases of pericardial effusion or cardiac tamponade. It is not indicated for the treatment of hypertrophic cardiomyopathy (HCM), which involves structural abnormalities of the heart muscle rather than pericardial fluid accumulation.
B. Septal myectomy: Septal myectomy is a surgical procedure performed to treat hypertrophic obstructive cardiomyopathy (HOCM), a subtype of hypertrophic cardiomyopathy characterized by thickening of the interventricular septum and dynamic left ventricular outflow tract obstruction. Septal myectomy involves the surgical removal of a portion of the hypertrophied septum to relieve left ventricular outflow tract obstruction and improve symptoms.
C. Pericardial window: A pericardial window is a surgical procedure used to create a communication between the pericardial sac and the pleural space, typically performed in cases of recurrent pericardial effusion or tamponade to prevent fluid re-accumulation. It is not indicated for the treatment of hypertrophic cardiomyopathy.
D. Synchronized electrical cardioversion: Synchronized electrical cardioversion is a procedure used to restore normal sinus rhythm in patients with certain types of cardiac arrhythmias, such as atrial fibrillation or atrial flutter. It is not typically indicated for the treatment of hypertrophic cardiomyopathy, although patients with HCM may develop arrhythmias as a complication.